A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
UCLB supports venture capital firm MTI to target new investment fund
10 February 2012
The Orion fund is being launched in a partnership between UCLB, MTI and the technology transfer offices of the Universities of Manchester and Edinburgh.
UCLB will work alongside UMI3 of the University of Manchester and ERI from the University of Edinburgh to identify investment opportunities in spin-outs, from the three universities.
Commenting on the initiative, Sir Richard Heygate of MTI said:
"The United Kingdom has always been one of the most innovative countries in the world, although sometimes it has lagged behind others in turning this creativity into world ranking businesses.
"Today, we have some of the highest ranked universities and business schools, a concentration of leading Private Equity, Venture Capital and other investment skills, a government committed to encouraging innovation and start-up businesses and a secure economy and currency.
"The new fund is well positioned to take advantage of all of these opportunities and create significant new wealth for our investors and our country."
Cengiz Tarhan, Managing Director of UCLB said "UCLB looks forward to working with MTI and is excited about this partnership which is set to bring in new money and established expertise to realise more spin-outs, from the world class research carried out at UCL. The Orion fund will be a welcome addition to the funding landscape".
UCLB is a leading technology transfer company that supports and commercialises research and innovations arising from UCL, one of the UK's top research-led universities.
UCLB has a successful track record and a strong reputation for identifying and protecting promising new technologies and innovations from UCL academics. It invests directly in development projects to maximise the potential of the research and manages the commercialisation process of technologies from the laboratory to market.
UCLB supports UCL's Grand Challenges of increasing UCL's positive impact on and contribution to Global Health, Sustainable Cities, Intercultural Interaction and Human Wellbeing.
For further information, please visit www.uclb.com
MTI is a leader in the field of technology venture capital, and one of the most successful and experienced technology fund managers in the UK. MTI has a sustained performance record across more than two decades and five venture funds. MTI's latest fund, The UMIP Premier Fund was raised in 2008 as Europe's largest institutional fund to have a single university focus, and works in partnership with the University of Manchester.
MTI has recently announced its intention to raise the new ORION Fund, to expand upon its successful investment strategy in UK University Intellectual Property.
To find out more information about MTI, please visit www.mtiventures.com